Navigation Links
Regado Biosciences Announces Publication in Circulation of Clinical Trial Results of REG1 Anticoagulation System
Date:6/5/2008

Regado's lead product candidate, REG1, is the first specific, direct-acting, antidote-controlled anticoagulant ever described. Regado is developing REG1 for use in patients suffering from acute coronary syndrome who undergo coronary revascularization procedures. These procedures, which include coronary artery bypass grafting (CABG) and percutaneous coronary intervention (PCI), put patients at a high-risk for therapy-related bleeding complications. REG1 is being developed initially to increase therapeutic flexibility and improve patient outcomes in coronary revascularization procedures.

REG1 is a two-component system, consisting of an aptamer-based anticoagulant and its matched antidote. The REG1 anticoagulant component (RB006) is a single-stranded, nucleic acid aptamer. RB006 selectively and potently binds to and inhibits Factor IXa, a protein that is critical to blood coagulation. The antidote component, RB007, is a complementary nucleic acid that binds to and neutralizes RB006. The binding of RB007 to RB006 causes the predictable and rapid reversal of RB006 that allows the patient's blood to return to normal.

About Regado Biosciences

Regado Biosciences is pioneering a new therapeutic field with the discovery and development of drug:antidote systems. Regado's drug:antidote systems are designed to give physicians the ability to fine-tune the therapeutic effect desired for each patient and in each setting. A spin-out of the Department of Surgery at Duke University Medical Center, Regado was created to answer the therapeutic needs identified by its scientific founders.

The Company's proprietary platform technology enables the discovery of oligonucleotide-based drug-antidote pairs to any target protein. Regado initially is focusing its discovery and development efforts on the acute care injectable antithrombotics, a multi-billion dollar market in need of therapeutics with improved safety profiles. Potential future indications for Regado's
'/>"/>

SOURCE Regado Biosciences
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Regado Biosciences Presents Early Stage Clinical Data for REG1 Anticoagulation System at American Heart Association 2007 Scientific Sessions
2. Regado Biosciences Presents Positive Data From REG1 Anticoagulation System Phase Ic Study at American Heart Association 2007 Scientific Sessions
3. Regado Biosciences Initiates Phase IIa Clinical Study of REG1 Anticoagulation System
4. Magellan Biosciences Companies to Feature Automated Products and New Tests for MRSA at the American Society for Microbiology Meeting, Booth 743
5. Ardea Biosciences Presents Preclinical Data on RDEA119 Demonstrating Favorable Anti-Inflammatory Profile for Potential Use in Ulcerative Colitis
6. Ardea Biosciences Identifies Lead Development Candidate for Gout, RDEA594
7. Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results
8. Catalyst Biosciences Selects Drug Development Candidate in Factor VIIa Program for Hemophilia
9. Neurocrine Biosciences Reports First Quarter 2008 Results
10. Ardea Biosciences Presents Data Demonstrating Favorable Pharmacokinetics and Efficacy for Mitogen-Activated ERK Kinase (MEK) Inhibitors
11. Sangamo BioSciences Announces Presentation of Data on ZFP Therapeutic for Glioblastoma at American Association for Cancer Research (AACR) Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... 2014  Major advances in radiation therapy and ... highlighted in a three-day Oncology Summit taking place ... 2014.  Renowned national and international cancer experts from seven ... exchange knowledge on modern technologies making treatment for ... The Summit will address a wide ...
(Date:7/10/2014)... SAN DIEGO , July 10, 2014  RESMED INC. ... report its fourth quarter and fiscal year ended June 30, ... York Stock Exchange market close. A press release with ResMed,s ... and the company will host a webcast to discuss operating ... scheduled to begin at 1:30 p.m. US Pacific Time and ...
(Date:7/10/2014)...  Decision Resources Group finds that while more ... are willing to prescribe Durata,s Dalvance (dalbavancin) and ... OPAT, approximately two-thirds of the respondents reported a ... inpatients. However, our findings indicate that nearly two-thirds ... OPAT following hospital discharge, and most are discharged ...
Breaking Medicine Technology:Improving quality and access to advanced cancer care in India and South Asia 2Improving quality and access to advanced cancer care in India and South Asia 3Improving quality and access to advanced cancer care in India and South Asia 4Improving quality and access to advanced cancer care in India and South Asia 5ResMed To Announce Fourth Quarter And Fiscal Year-End 2014 Results 2Long-Acting Antibiotics Offering Once-Weekly Dosing Will See Favorable Uptake and Use as Outpatient Parenteral Antimicrobial Therapy (OPAT) 2Long-Acting Antibiotics Offering Once-Weekly Dosing Will See Favorable Uptake and Use as Outpatient Parenteral Antimicrobial Therapy (OPAT) 3
... 2 Questcor Pharmaceuticals, Inc . (Nasdaq: QCOR ) announced ... on Thursday, June 10, 2010 at The Grand Hyatt Hotel in ... Chief Executive Officer, will discuss the Company,s business strategy and historical financial performance ... , , ...
... CUPERTINO, Calif. , June 1 DURECT Corporation (Nasdaq: DRRX ) ... be presenting at the Jefferies Global Life Sciences Conference on Thursday, June 10 ... the Grand Hyatt Hotel in New York .   , ... (Logo:   http://www.newscom.com/cgi-bin/prnh/20020717/DRRXLOGO ) , , ...
Cached Medicine Technology:Questcor to Present at the Jefferies 2010 Global Life Sciences Conference 2DURECT to Present at the Jefferies Global Life Sciences Conference 2
(Date:7/12/2014)... 12, 2014 Sean Francis, owner of the Kawartha ... challenges to his clients. He’s also known for his support of ... a way to combine the two and is excited to announce ... the Boys and Girls Club. , The funds are the result ... June 23rd. Francis sent out emails and asked his clients to ...
(Date:7/12/2014)... For those who are unfamiliar with enzymes, they are ... in food. The enzymes literally break up the vitamins and ... absorbed by human bodies. According Dr. Henry Balzani, Medical Consultant ... food is the cause of many gastrointestinal health issues. ... DelPresto, a mother of 3 who is passionate about fitness ...
(Date:7/12/2014)... Lake City, Utah (PRWEB) July 12, 2014 ... spotlighted two types of startups, with awards being bestowed ... new emphasis spotlighted Utah’s outstanding entrepreneur community with recognition ... proving a sustainable model with incoming revenue. , 25 ... from across the state that are under 5 years ...
(Date:7/12/2014)... (PRWEB) July 12, 2014 Restore My ... Sen and Samantha Pearson, a couple boasting very impressive ... launch Restore My Vision Today as a way to ... ophthalmologists have become in their respective patients’ treatments ... privy to a “secret” trove of pertinent information relevant ...
(Date:7/11/2014)... Recently, MagicQuinceaneraDresses.com, the popular online supplier ... of 2014 Quinceanera dresses . The company’s new ... look fashionable without paying a large amount of money. ... 57% off. , The company’s online shop has become ... special occasion outfits. In addition to exquisite Quinceanera dresses, ...
Breaking Medicine News(10 mins):Health News:Kawartha Lakes Fit Body Boot Camp’s Successful Fat Loss Challenge Results in $2,000 to Boys and Girls Club 2Health News:Kawartha Lakes Fit Body Boot Camp’s Successful Fat Loss Challenge Results in $2,000 to Boys and Girls Club 3Health News:New Super Digestive Enzyme, DZ10, Supercharges The Digestion Process 2Health News:SquareHook is Recognized for UVEF 25 Businesses Under 5 Years-Watch Out 2Health News:Restore My Vision Today | Groundbreaking Book Reveals How To Restore Your Vision Without The Use of Glasses – Vinamy 2Health News:Restore My Vision Today | Groundbreaking Book Reveals How To Restore Your Vision Without The Use of Glasses – Vinamy 3Health News:Cheap Quinceanera Dresses Now Available At MagicQuinceaneraDresses.com 2
... 1 When Madonna sets out to adopt a child, ... people are being introduced to Malawi -- a small impoverished ... orphaned children range from 500,000 to over a million, help ... are raised in nurturing homes, with a mother and siblings, ...
... Honors Award(TM)RIDGEFIELD, Conn., April 1 Boehringer ... Association of Diversity Councils with the organization,s ... award recognizes the outstanding contributions of the ... lead diversity processes in their organizations and ...
... Pro:Idiom , Enable MSOs to Conveniently Deliver HD ... R.L. Drake , an American cable TV equipment ... solutions for over 65 years, has checked in as ... cable operators in the United States and Canada. ...
... exchange technology gives patients initial breast cancer screening ... unit FARMERVILLE, La., April 1 A breakthrough ... first time to over-40 women who live in ... http://www.newscom.com/cgi-bin/prnh/20090401/NY92660 ) ...
... with vascular birthmarks around the eye, even partial blockage ... amblyopia. Now a simple test can detect early ... vision testing, reports a study in the April issue ... http://www.elsevier.com/locate/ajo ) published by Elsevier. , Led by Dr. ...
... it Takes to Form a New Habit; Lack of Motivation ... Conn., April 1 According to ... brand bottled water, the number one bottled water brand in ... months or longer to form a new habit. However, experts ...
Cached Medicine News:Health News:In Malawi, Adoption is Not Enough 2Health News:Boehringer Ingelheim Recognized For Diversity And Inclusion Efforts 2Health News:Drake Nabs 'Suite Deal' as Distributor of Pro:Idiom(R) Hospitality Solution to U.S. and Canadian Cable Operators 2Health News:New Mobile Mammography Unit Offers Residents of Rural Northern Louisiana First-Ever Access to Free Breast Cancer Screening Exams 2Health News:New Mobile Mammography Unit Offers Residents of Rural Northern Louisiana First-Ever Access to Free Breast Cancer Screening Exams 3Health News:New Mobile Mammography Unit Offers Residents of Rural Northern Louisiana First-Ever Access to Free Breast Cancer Screening Exams 4Health News:Test allows early detection of vision problems in infants with hemangiomas of eyelids 2Health News:Video: New Survey Reveals Misconceptions About Forming New Habits 2Health News:Video: New Survey Reveals Misconceptions About Forming New Habits 3Health News:Video: New Survey Reveals Misconceptions About Forming New Habits 4
Double Ended Occluders...
Double Ended Occluders...
Designed to provide occlusion while permitting observation of the eye. Helpful to determine if only one eye is deviating. Approximately 9 inches long....
Short handle occluders are about 6 inches long....
Medicine Products: